Enterprise Value
$4.34 B
-$17.06 M-0.39%
Fri, 29 Nov 2024 21:58:05 GMT
Summary:
CRISPR Therapeutics AG enterprise value is currently $4.34 billion, with a fall of -$17.06 million (-0.39%) during the most recent trading day. Over the past year, it has dropped by -$872.71 million (-16.75%). CRSP enterprise value is now -69.91% below its all-time high of $14.42 billion.CRSP Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -0.4% | -0.4% | -0.4% |
| 1 m1 month | +4.3% | +4.3% | +4.3% |
| 3 m3 months | +12.9% | +5.9% | +5.6% |
| 6 m6 months | +7.5% | -3.8% | -4.3% |
| ytdytd | -11.0% | -13.7% | -19.1% |
| 1 y1 year | -16.8% | -21.1% | -26.6% |
| 5 y5 years | +15.9% | +0.1% | -29.1% |
CRSP Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $4.74 B | -8.5% | $3.98 B | +9.0% |
| 3 m | 3 months | $4.74 B | -8.5% | $3.57 B | +21.5% |
| 6 m | 6 months | $5.12 B | -15.3% | $3.57 B | +21.5% |
| 1 y | 1 year | $7.36 B | -41.1% | $3.57 B | +21.5% |
| 3 y | 3 years | $7.36 B | -41.1% | $2.79 B | +55.3% |
| 5 y | 5 years | $14 B | -69.9% | $1.16 B | +274.1% |
| alltime | all time | $14 B | -69.9% | $256 M | +1595.2% |
CRISPR Therapeutics AG Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $4.34 B(-11.0%) |
| 2023 | $4.88 B(+47.2%) |
| 2022 | $3.31 B(-35.5%) |
| 2021 | $5.14 B(-49.7%) |
| Date | Value |
|---|---|
| 2020 | $10.21 B(+263.2%) |
| 2019 | $2.81 B(+174.3%) |
| 2018 | $1.02 B(+43.7%) |
| 2017 | $713.35 M(+45.8%) |
| 2016 | $489.20 M |
FAQ
- What is CRISPR Therapeutics AG enterprise value?
- What is the all time high enterprise value for CRISPR Therapeutics AG?
- What is CRSP enterprise value year-to-date change?
- What is CRISPR Therapeutics AG enterprise value year-on-year change?
What is CRISPR Therapeutics AG enterprise value?
The current enterprise value of CRSP is $4.34 B
What is the all time high enterprise value for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high enterprise value is $14.42 B
What is CRSP enterprise value year-to-date change?
CRISPR Therapeutics AG enterprise value has changed by -$537.31 M (-11.02%) since the beginning of the year
What is CRISPR Therapeutics AG enterprise value year-on-year change?
Over the past year, CRSP enterprise value has changed by -$872.71 M (-16.75%)